Mark Weeks
About Mark
Mark Weeks specializes in corporate and securities law with an emphasis on representing emerging and public growth companies, as well as investment banking firms and venture capital investors. Mark counsels companies throughout their lifecycle on matters ranging from pre-incorporation planning, company formations, fundraising strategies, private financings, IPOs and follow-on equity and debt offerings as well as M&A, spinoffs and other complex business collaborations, corporate governance and SEC reporting. He has represented companies and investment banks in well over 200 public offerings.
Experience
-
Belhaven Biopharma Closes Oversubscribed $11 Million Series A
-
Allay Therapeutics Secures $57.5 Million Series D
-
NeuroPace Secures up to $75 Million in Debt Financing
-
Beta Bionics Announces Upsized $234.6 Million IPO, Concurrent $17 Million Private Placement
-
Sword Health Raises $130 Million in a Mix of Primary and Secondary Sales
Admissions and credentials
- California
Rankings and accolades
Chambers USA: Life Sciences: Corporate/Commercial – California (2020 – 2025)
Adept at representing and advising emerging life sciences companies throughout their growth, from pre-incorporation to M&A.
Get In Touch
Location
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.